Dallan Murray Sarepta Therapeutics, Inc. (SRPT) insider trading activity
Dallan Murray is Chief Customer Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 22,023 shares of SRPT, which is worth approximately $2.84 Million. The most recent transaction as insider was on Jun 24, 2024, when has been sold 2,352 shares (Common Stock) at a price of $164.64 per share, resulting in proceeds of $387,233. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
22K
21.51%
3M change
n/a
12M change
Total Value Held
$2.84 Million
Dallan Murray Transaction History
DM
Dallan Murray
Chief Customer Officer
Cambridge, MA